Why BioNTech trounced the Market on Tuesday

Shareholders might be getting a small present from the company before long.

| More on:
Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

BioNTech's (NASDAQ: BNTX) shares rose higher than that of the Nasdaq Composite index on Tuesday, which is impressive given that the latter vaulted a new all-time record. The company's stock advanced by 4.6% on the back of some happily surprising news for its investors.

So what

In its annual shareholder meeting on Tuesday, BioNTech's COO and CFO Sierk Poetting revealed the company is considering a shareholder dividend

"In the next financial year, the Management Board and the Supervisory Board will examine, in accordance with the legal and statutory provisions, whether and in what amount a resolution on the distribution of dividends should be proposed to the Annual General Meeting," he said.

Poetting did not speculate about said amount, nor did he provide a more specific time frame. He did point out that, thanks in no small part to the flotation of new stock last year, the biotech's cash and cash equivalents more than doubled year over year at the end of 2020. As of Dec. 31 of that year, they stood at slightly over 1.21 billion euros ($1.44 billion), from the end-of-2019 tally of 519 million euros ($617 million).

Now what

BioNTech is busy developing messenger RNA (mRNA) treatments such as the wildly successful BNT162b2 coronavirus vaccine it collaborated on with Pfizer. While a dividend will make the stock that much more attractive, it likely won't be large, given the ambitious biotech's still-considerable need to spend capital in other areas (notably research and development).

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News

A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.
International Stock News

What did Nasdaq high flyers Tesla and Alphabet just report?

Nasdaq earnings season continues with Google-parent Alphabet and Tesla reporting overnight.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
International Stock News

Nvidia stock has pulled back over 10%. Here's what history says could happen next

Nvidia has a 100% success rate of rebounding after pullbacks of 10% or more. Will this time be different?

Read more »

Digital rocket on a laptop.
International Stock News

Why Nvidia stock jumped on Monday

Nvidia investors got some big news, and the stock is also getting a boost thanks to bullish Wall Street analysts.

Read more »

a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
International Stock News

Why CrowdStrike stock just crashed again

There likely isn't a quick way to restore confidence.

Read more »

A man wearing a suit and holding an EV charger gives the thumbs up.
International Stock News

Why Tesla stock popped ahead of earnings day

Investors will soon see what Tesla's surprising Q2 sales volume means for the bottom line.

Read more »

A little Asian girl is so excited by the bubbles coming out of her bubble machine.
International Stock News

Opinion: This Nvidia forecast all but confirms that the artificial intelligence (AI) bubble will burst sooner rather than later

Nvidia's gross margin guidance points to pricing pressures that may signal an end to the irrational exuberance surrounding artificial intelligence…

Read more »

Hands reaching high for a trophy with a sunset in the background.
International Stock News

Is it too late to buy Nvidia stock in the second half of 2024?

The company has suffered from a recent sell-off, but maintains massive long-term potential.

Read more »

A white EV car and an electric vehicle pump with green highlighted swirls representing ASX lithium shares
International Stock News

Why Tesla could be the best 'Magnificent Seven' stock to own in the second half of 2024

Tesla's stock has been rallying of late, and there could be more gains to come in the weeks and months…

Read more »